Article ID Journal Published Year Pages File Type
6069761 Journal of the American Academy of Dermatology 2016 6 Pages PDF
Abstract
Our study indicates that the addition of rituximab to conventional therapy in patients with MMP results in more rapid and sustained disease control with potentially fewer adverse events.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, , , , , , ,